{"id":877646,"date":"2025-08-20T16:43:23","date_gmt":"2025-08-20T20:43:23","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events\/"},"modified":"2025-08-20T16:43:23","modified_gmt":"2025-08-20T20:43:23","slug":"tyra-biosciences-announces-participation-at-upcoming-investor-events","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events\/","title":{"rendered":"Tyra Biosciences Announces Participation at Upcoming Investor Events"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">CARLSBAD, Calif.<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Aug. 20, 2025<\/span><\/span> \/PRNewswire\/ &#8212; Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, announced today that members of company management will participate in the following investor events:<\/p>\n<p>\u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Virtual H.C. Wainwright &#8220;HCW@Home&#8221; series<br \/>\u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Format: Fireside chat<br \/>\u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Presentation Date\/Time: <span class=\"xn-chron\">Thursday, August 21, 2025<\/span>, at <span class=\"xn-chron\">11 AM ET<\/span><\/p>\n<p>\u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0H.C. Wainwright 27<sup>th<\/sup> Annual Global Investment Conference<br \/>\u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Format: Fireside chat and one-on-one investor meetings<br \/>\u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Presentation Date\/Time: <span class=\"xn-chron\">Wednesday, September 10, 2025<\/span>, at <span class=\"xn-chron\">9 AM ET<\/span><br \/>\u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Location: <span class=\"xn-location\">New York, NY<\/span><\/p>\n<p>\n        <span>A live webcast of the events can be accessed by visiting the &#8220;For Investors&#8221; page on the Tyra Biosciences <\/span><br \/>\n        <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4492013-1&amp;h=1419926496&amp;u=https%3A%2F%2Fir.tyra.bio%2F&amp;a=website\" target=\"_blank\" rel=\"nofollow\"><br \/>\n          <span>website<\/span><br \/>\n        <\/a><br \/>\n        <span> and will be available for replay following the event.<\/span>\n      <\/p>\n<p>\n        <b>About Tyra Biosciences<\/b>\n      <\/p>\n<p>Tyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in FGFR biology. TYRA&#8217;s in-house precision medicine platform, SN\u00c5P, enables rapid and precise drug design through iterative molecular SN\u00c5Pshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. TYRA&#8217;s expertise in FGFR biology has created a differentiated pipeline with clinical-stage programs in targeted oncology and genetically defined conditions. TYRA&#8217;s lead precision medicine stemming from SN\u00c5P, dabogratinib, is a potential first-in-class selective FGFR3 inhibitor that is designed to avoid the toxicities associated with inhibition of FGFR1, FGFR2 and FGFR4, while being agnostic for FGFR3 gatekeeper mutations. The current planned clinical development for dabogratinib includes SURF302 for intermediate risk non-muscle invasive bladder cancer, BEACH301 for pediatric achondroplasia, and potentially future metastatic urothelial cancer studies. TYRA is also developing TYRA-430, an oral, investigational FGFR4\/3-biased inhibitor for FGF19+\/FGFR4-driven cancers, in the SURF431 study for advanced hepatocellular carcinoma, and TYRA-200, an oral, investigational, FGFR1\/2\/3 inhibitor, in the SURF201 study for metastatic intrahepatic cholangiocarcinoma. TYRA is based in <span class=\"xn-location\">Carlsbad, CA.<\/span><\/p>\n<p>For more information about our science, pipeline and people, please visit\u00a0<b><u><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4492013-1&amp;h=3930404010&amp;u=https%3A%2F%2Furl.avanan.click%2Fv2%2F___https%3A%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4345295-1%26h%3D1626033245%26u%3Dhttps%253A%252F%252Furl.avanan.click%252Fv2%252F___http%253A%252Fwww.tyra.bio___.YXAzOnR5cmExOmE6bzo5OTg0OTgwMGE1ZDdlYTIxMjM5ZTRmZjg2NzVmMGE1MTo2OjQ1ODA6MzY0YmE4ZTc0NGQyYWZiZWFjZTJkZTBjMTE5M2RlN2Q0YjZlZGQzMDAwMTQ3MGFhZjAzYzU0NmI1NjI0ZDFjMDpwOlQ6Rg%26a%3Dwww.tyra.bio___.YXAzOnR5cmExOmE6bzo1NzFiZGViY2Q3ZDM4OGYxN2JkZDJjMGY3YzVkYmUyODo2OjA3NDQ6OWE3ZGZkMGE4MjU0MmJlOWVhOTVjOTdjMTZlOTQ4NTU5MWJlOGRmODBmZDIzNjU0MzNmNDI1ZDA5MWI5NmJiODpwOlQ6Rg&amp;a=www.tyra.bio\" target=\"_blank\" rel=\"nofollow\">www.tyra.bio<\/a><\/u><\/b>\u00a0and engage with us on\u00a0<b><u><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4492013-1&amp;h=2578644474&amp;u=https%3A%2F%2Furl.avanan.click%2Fv2%2F___https%3A%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4345295-1%26h%3D3971599602%26u%3Dhttps%253A%252F%252Furl.avanan.click%252Fv2%252F___https%253A%252Fwww.linkedin.com%252Fcompany%252Ftyra-biosciences%252F%253FviewAsMember%253Dtrue___.YXAzOnR5cmExOmE6bzo5OTg0OTgwMGE1ZDdlYTIxMjM5ZTRmZjg2NzVmMGE1MTo2OjJiNWQ6NWQwYTE0ZTczYjg2NDg4ZTZhNzBhNGE1N2VkNzNhMTYyYTI3NGFlM2EwYjc5MWRmZjY5NGQzMjNjMjYyNmUyNjpwOlQ6Rg%26a%3DLinkedIn___.YXAzOnR5cmExOmE6bzo1NzFiZGViY2Q3ZDM4OGYxN2JkZDJjMGY3YzVkYmUyODo2OjAwM2Q6NmQzNWZhYTdiN2QxZjIzNGY3MzU1MzE1YjU1N2Y2NTkyZTIxNTIwNzBiYTIzNzczY2M4M2JjYTZkZTdjMGI1YTpwOlQ6Rg&amp;a=LinkedIn\" target=\"_blank\" rel=\"nofollow\">LinkedIn<\/a><\/u><\/b>.<\/p>\n<p>\n        <b>Contact:<\/b>\n      <\/p>\n<p>\n        <span class=\"xn-person\">Amy Conrad<\/span><br \/>\n        <br \/>\n        <u><br \/>\n          <a href=\"mailto:aconrad@tyra.bio\" target=\"_blank\" rel=\"nofollow\">aconrad@tyra.bio<\/a><br \/>\n        <\/u>\n      <\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder3023\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1626125\/Tyra_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1626125\/Tyra_Logo.jpg\" title=\"(PRNewsfoto\/Tyra Biosciences, Inc.)\" alt=\"(PRNewsfoto\/Tyra Biosciences, Inc.)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder0\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA55281&amp;sd=2025-08-20\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/tyra-biosciences-announces-participation-at-upcoming-investor-events-302534890.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/tyra-biosciences-announces-participation-at-upcoming-investor-events-302534890.html<\/a><\/p>\n<p>SOURCE  Tyra Biosciences<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=LA55281&amp;Transmission_Id=202508201605PR_NEWS_USPR_____LA55281&amp;DateId=20250820\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire CARLSBAD, Calif. , Aug. 20, 2025 \/PRNewswire\/ &#8212; Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, announced today that members of company management will participate in the following investor events: \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Virtual H.C. Wainwright &#8220;HCW@Home&#8221; series\u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Format: Fireside chat\u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Presentation Date\/Time: Thursday, August 21, 2025, at 11 AM ET \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0H.C. Wainwright 27th Annual Global Investment Conference\u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Format: Fireside chat and one-on-one investor meetings\u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Presentation Date\/Time: Wednesday, September 10, 2025, at 9 AM ET\u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Location: New York, NY A live webcast of the events can be accessed by visiting the &#8220;For Investors&#8221; page &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Tyra Biosciences Announces Participation at Upcoming Investor Events&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-877646","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Tyra Biosciences Announces Participation at Upcoming Investor Events - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tyra Biosciences Announces Participation at Upcoming Investor Events - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire CARLSBAD, Calif. , Aug. 20, 2025 \/PRNewswire\/ &#8212; Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, announced today that members of company management will participate in the following investor events: \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Virtual H.C. Wainwright &#8220;HCW@Home&#8221; series\u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Format: Fireside chat\u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Presentation Date\/Time: Thursday, August 21, 2025, at 11 AM ET \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0H.C. Wainwright 27th Annual Global Investment Conference\u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Format: Fireside chat and one-on-one investor meetings\u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Presentation Date\/Time: Wednesday, September 10, 2025, at 9 AM ET\u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Location: New York, NY A live webcast of the events can be accessed by visiting the &#8220;For Investors&#8221; page &hellip; Continue reading &quot;Tyra Biosciences Announces Participation at Upcoming Investor Events&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-20T20:43:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1626125\/Tyra_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tyra-biosciences-announces-participation-at-upcoming-investor-events\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tyra-biosciences-announces-participation-at-upcoming-investor-events\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Tyra Biosciences Announces Participation at Upcoming Investor Events\",\"datePublished\":\"2025-08-20T20:43:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tyra-biosciences-announces-participation-at-upcoming-investor-events\\\/\"},\"wordCount\":359,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tyra-biosciences-announces-participation-at-upcoming-investor-events\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1626125\\\/Tyra_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tyra-biosciences-announces-participation-at-upcoming-investor-events\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tyra-biosciences-announces-participation-at-upcoming-investor-events\\\/\",\"name\":\"Tyra Biosciences Announces Participation at Upcoming Investor Events - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tyra-biosciences-announces-participation-at-upcoming-investor-events\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tyra-biosciences-announces-participation-at-upcoming-investor-events\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1626125\\\/Tyra_Logo.jpg\",\"datePublished\":\"2025-08-20T20:43:23+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tyra-biosciences-announces-participation-at-upcoming-investor-events\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tyra-biosciences-announces-participation-at-upcoming-investor-events\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tyra-biosciences-announces-participation-at-upcoming-investor-events\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1626125\\\/Tyra_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1626125\\\/Tyra_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tyra-biosciences-announces-participation-at-upcoming-investor-events\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tyra Biosciences Announces Participation at Upcoming Investor Events\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tyra Biosciences Announces Participation at Upcoming Investor Events - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events\/","og_locale":"en_US","og_type":"article","og_title":"Tyra Biosciences Announces Participation at Upcoming Investor Events - Market Newsdesk","og_description":"PR Newswire CARLSBAD, Calif. , Aug. 20, 2025 \/PRNewswire\/ &#8212; Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, announced today that members of company management will participate in the following investor events: \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Virtual H.C. Wainwright &#8220;HCW@Home&#8221; series\u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Format: Fireside chat\u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Presentation Date\/Time: Thursday, August 21, 2025, at 11 AM ET \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0H.C. Wainwright 27th Annual Global Investment Conference\u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Format: Fireside chat and one-on-one investor meetings\u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Presentation Date\/Time: Wednesday, September 10, 2025, at 9 AM ET\u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Location: New York, NY A live webcast of the events can be accessed by visiting the &#8220;For Investors&#8221; page &hellip; Continue reading \"Tyra Biosciences Announces Participation at Upcoming Investor Events\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events\/","og_site_name":"Market Newsdesk","article_published_time":"2025-08-20T20:43:23+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1626125\/Tyra_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Tyra Biosciences Announces Participation at Upcoming Investor Events","datePublished":"2025-08-20T20:43:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events\/"},"wordCount":359,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1626125\/Tyra_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events\/","name":"Tyra Biosciences Announces Participation at Upcoming Investor Events - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1626125\/Tyra_Logo.jpg","datePublished":"2025-08-20T20:43:23+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1626125\/Tyra_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1626125\/Tyra_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Tyra Biosciences Announces Participation at Upcoming Investor Events"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/877646","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=877646"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/877646\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=877646"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=877646"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=877646"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}